皮质基底节变性中脑脊液蛋白质的改变 - Suppr | 超能文献

相似文献

1

Cerebrospinal Fluid Proteins Altered in Corticobasal Degeneration.皮质基底节变性中脑脊液蛋白质的改变

Mov Disord. 2021 May;36(5):1278-1280. doi: 10.1002/mds.28543. Epub 2021 Mar 4.

2

Increased CSF tau protein in corticobasal degeneration.皮质基底节变性中脑脊液tau蛋白升高。

J Neurol. 1998 Jan;245(1):44-6. doi: 10.1007/s004150050173.

3

Cerebrospinal fluid biomarker profiling in corticobasal degeneration: Application of the AT(N) and other classification systems.皮质基底节变性的脑脊液生物标志物分析：AT(N)和其他分类系统的应用。

Parkinsonism Relat Disord. 2021 Jan;82:44-49. doi: 10.1016/j.parkreldis.2020.11.016. Epub 2020 Nov 20.

4

Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome.阿尔茨海默病患者以皮质基底节综合征为表现的临床、神经心理学和影像学特征。

J Neurol Sci. 2019 Mar 15;398:142-147. doi: 10.1016/j.jns.2019.01.046. Epub 2019 Jan 29.

5

Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.tau蛋白在皮质基底节变性或进行性核上性麻痹患者脑脊液中的诊断意义。

J Neurol Sci. 2001 Jan 15;183(1):95-8. doi: 10.1016/s0022-510x(00)00480-9.

6

Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.进行性核上性麻痹和皮质基底节变性患者脑脊液中β-淀粉样肽42减少。

J Neurol Sci. 2005 Oct 15;237(1-2):61-5. doi: 10.1016/j.jns.2005.05.015.

7

Corticobasal degeneration with hippocampal involvement.

Clin Neuropathol. 1999 Mar-Apr;18(2):106-8.

8

Current and future management of the corticobasal syndrome and corticobasal degeneration.皮质基底节综合征和皮质基底节变性的当前及未来管理

Handb Clin Neurol. 2008;89:533-48. doi: 10.1016/S0072-9752(07)01249-3.

9

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.暴发性皮质基底节变性：一种以神经元 Tau 聚集体为主的独特变异型。

Acta Neuropathol. 2020 Apr;139(4):717-734. doi: 10.1007/s00401-019-02119-4. Epub 2020 Jan 16.

10

The glial marker YKL-40 is decreased in synucleinopathies.神经胶质标志物 YKL-40 在突触核蛋白病中减少。

Mov Disord. 2013 Nov;28(13):1882-5. doi: 10.1002/mds.25589. Epub 2013 Jul 11.

引用本文的文献

1

Biological signatures in the Alzheimer's continuum discriminate between diagnosis-related and -unrelated associations to ATN categories.阿尔茨海默病连续体中的生物学特征区分了与ATN分类相关和不相关的诊断关联。

Brain Commun. 2025 Feb 21;7(2):fcaf078. doi: 10.1093/braincomms/fcaf078. eCollection 2025.

2

Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases.解决神经退行性疾病中脑源性蛋白质脑脊液水平的个体间差异。

Sci Rep. 2025 Jan 3;15(1):668. doi: 10.1038/s41598-024-83281-y.

3

Secretome Analyses Identify FKBP4 as a -Associated Protein in CSF and iPS Cells from Parkinson's Disease Patients with Mutations.